Pharma-Bio Serv (PBSV) Accumulated Depreciation & Amortization (2016 - 2025)
Pharma-Bio Serv filings provide 14 years of Accumulated Depreciation & Amortization readings, the most recent being $199929.0 for Q4 2025.
- On a quarterly basis, Accumulated Depreciation & Amortization fell 69.63% to $199929.0 in Q4 2025 year-over-year; TTM through Oct 2025 was $199929.0, a 69.63% decrease, with the full-year FY2025 number at $199929.0, down 69.63% from a year prior.
- Accumulated Depreciation & Amortization hit $199929.0 in Q4 2025 for Pharma-Bio Serv, down from $658249.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $658249.0 in Q4 2024 to a low of $199929.0 in Q4 2025.
- Median Accumulated Depreciation & Amortization over the past 5 years was $587089.0 (2022), compared with a mean of $523732.0.
- Biggest five-year swings in Accumulated Depreciation & Amortization: rose 9.05% in 2022 and later plummeted 69.63% in 2025.
- Pharma-Bio Serv's Accumulated Depreciation & Amortization stood at $538384.0 in 2021, then grew by 9.05% to $587089.0 in 2022, then grew by 8.16% to $635009.0 in 2023, then grew by 3.66% to $658249.0 in 2024, then plummeted by 69.63% to $199929.0 in 2025.
- The last three reported values for Accumulated Depreciation & Amortization were $199929.0 (Q4 2025), $658249.0 (Q4 2024), and $635009.0 (Q4 2023) per Business Quant data.